Summary:
In this podcast, first recorded at the 2024 IO360º Summit, six cell therapy manufacturing experts bring forward the lessons they've learned to discuss tackling existing and novel challenges in producing cell-based immunotherapies, including:
- Streamlining collaboration between manufacturer and sponsor
- Number of manufacturing sites
- Phase-appropriate process development
For more information, visit IO360summit.com.
Moderators
Bruce Levine, PhD
Barbara and Edward Netter Professor in Cancer Gene Therapy
University of Pennsylvania
Speakers
Arvind Natarajan, PhD, MBA
SVP, Process and Analytical Development
Iovance Biotherapeutics Inc
Greg Russotti, PhD
Chief Technology and Manufacturing Officer
Century Therapeutics
Shishir Gadam, PhD
Chief Technical Officer
Cargo Therapeutics
Jessica Carmen, PhD
Vice President of Business Development
Kincell Bio
Angela Chen, PhD
Chief Business Officer
WuXi Advanced Therapies
This content was created by The Conference Forum staff. The Fierce editorial team did not contribute to this work.